Estrogen receptors in human prostate: evidence for multiple binding sites

Area of Science:

• Endocrinology
• Urology
• Molecular Biology

Background:

• The presence and role of estrogen receptors in the human prostate have been debated.
• Prostatic tissue exhibits apparent heterogeneity in estrogen-binding sites, complicating research.

Purpose of the Study:

• To investigate and characterize multiple estrogen binding sites in human prostate cytosol and nuclear preparations.
• To clarify the impact of different binding site affinities on estrogen receptor studies.

Main Methods:

• Utilized [3H]estradiol to identify and quantify estrogen binding sites in human prostate tissues.
• Performed saturation analysis over a wide range of ligand concentrations (0.05-10 nM).
• Examined cytosol, nuclear salt-extractable, and salt-resistant compartments of normal, hyperplastic, and cancerous prostates.

Main Results:

• Identified two distinct classes of estrogen binding sites: a high-affinity receptor (Kd ≈ 0.10 nM) and a lower-affinity site (Kd ≈ 5-10 nM).
• The low-affinity sites significantly influenced measurements of the classical estrogen receptor, especially at low concentrations.
• Normal and cancerous prostates had higher cytosol estrogen receptor levels than benign hyperplastic tissue.

Conclusions:

• Human prostate cytosol and nuclear fractions contain multiple estrogen binding sites.
• Accurate quantification of estrogen receptors requires accounting for both high- and low-affinity binding, potentially by blocking the low-affinity component.
• Estrogen receptor levels differ significantly across normal, benign hyperplastic, and cancerous prostate tissues.